Randomized Phase II Study of Paclitaxel Plus Metformin or Placebo for the Treatment of Platinum-refractory, Recurrent or Metastatic Head and Neck Neoplasms
Phase of Trial: Phase II
Latest Information Update: 26 Jan 2015
At a glance
- Drugs Metformin (Primary) ; Paclitaxel (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- Acronyms METTAX
- 13 May 2013 Planned End Date changed from 1 Jul 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 28 Aug 2012 Planned End Date changed from 1 Dec 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 15 Apr 2011 New trial record